NCT02634008View on ClinicalTrials.gov

Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P

PHASE3CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Hepatitis C, Acute
Interventions
DRUG

Paritaprevir/ritonavir/ombitasvir

DRUG

Dasabuvir

DRUG

Ribavirin

DRUG

Glecaprevir/pibrentasvir

Trial Locations (11)

1023

Auckland City Hospital, Auckland

2010

St Vincent's Hospital, Sydney

3004

Alfred Hospital, Melbourne

5000

Royal Adelaide Hospital, Adelaide

8011

Christchurch Hospital, Christchurch

EC1A 7BE

Barts and London, London

NW3 2QG

Royal Free Hospital, London

SE1 7EH

Guy's and St Thomas' Hospital, London

SW10 9NH

Chelsea and Westminster Hospital, London

W2 1NY

St Mary's Hospital, London

M8 5RB

Pennine Acute Hospital, Manchester

Sponsors

Lead Sponsor

Kirby Institute

Collaborators (1)

AbbVie
All Listed Sponsors
collaborator

AbbVie

INDUSTRY

lead

Kirby Institute

OTHER_GOV